Based on 1 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$4.50
+478.3% upside
Average target across 1 active firms as of Nov 19, 2026 vs $0.78 current
Highest Target$4.50
Average Target$4.50
Lowest Target$4.50
UXIN analyst recommendation trends
86420
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Strong BuyBuyNeutralSellStrong Sell
RATING
JUN
JUL
AUG
SEP
OCT
NOV
Strong Buy
0
0
0
0
0
0
Buy
1
1
1
1
1
1
Neutral
0
0
0
0
0
0
Sell
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
Total
1
1
1
1
1
1
As of Nov 19, 2026, 1 of 1 active firms rate UXIN a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
UXIN EPS & revenue forecast
EPS · NEXT QUARTER
$0.00
Range $0.00 – $0.00 · 0 analysts · -100% YoY
Next period, 0 analysts expect Uxin Ltd to earn $0.00 a share (range $0.00 – $0.00), versus $-0.30 a year earlier. Full-year consensus is $-0.01, growing to $-0.00 the year after.
REVENUE · NEXT QUARTER
—
Range — – — · 0 analysts
Revenue is expected to reach — (range — – —). Full-year consensus is $5.2B, rising to $8.9B next year.
UXIN stock forecast FAQ
What is UXIN's average 12-month price target?+
The 1 active firms with a live target average $4.50 for Uxin Ltd over the next 12 months, ranging from a $4.50 high to a $4.50 low, as of Nov 19, 2026.
Is UXIN stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover UXIN?+
1 active firms have a recognized rating on Uxin Ltd as of Nov 19, 2026, and 1 active firms carry a live 12-month price target.
What is Uxin Ltd's projected EPS for next quarter?+
The consensus estimate is $0.00 per share (range $0.00 – $0.00) across 0 analysts. Full-year EPS is projected at $-0.01, rising to $-0.00 the following year.
How much revenue is Uxin Ltd expected to report next quarter?+
Consensus revenue is — (range — – —). Full-year revenue is projected at $5.2B, growing to $8.9B next year.
Have analysts been upgrading or downgrading UXIN lately?+
As of Nov 19, 2026, 1 of 1 active firms rate UXIN a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their UXIN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.